Amides

Please enquire for more information about 4,5,6,7-Tetrahydro-1,2-benzisoxazole-3-carboxamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

S03379 - (3S 4S)-3-[ (R)-1-(T-Butyldimethylsilyloxy)ethyl]-4[(R)-1-carboxyethyl]-2-azetidinone

Please enquire for more information about N,N'-[1,3-Phenylenebis(oxyethane-2,1-diyl)]diacetamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

1-Aminocycloheptanecarboxamide (1ACA) belongs to a new class of compounds that are being investigated for their ability to block voltage-gated sodium channels. It has been found to be biologically active in vivo and in vitro. 1ACA blocks the channel by binding to the pentylenetetrazole site, which is located at the entrance of the pore. This binding prevents ions from entering or exiting through the channel, leading to a cessation of neural activity. 1ACA also binds to other sites on the channel and prevents ion flow through it. Furthermore, 1ACA inhibits branched-chain aminotransferase, an enzyme involved in amino acid metabolism and cell proliferation. This agent has shown potential as a drug for treating epilepsy and schizophrenia.

Applications Precursor of Diazopropane. Carcinogen. References Hecker, L.I., et al.: Cancer Res., 43, 4078 (1983),

Please enquire for more information about 2-Chloro-N-{4-[(3,5-dimethylpiperidin-1-yl)sulfonyl]phenyl}acetamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about trans-Cotinine amide including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about N-[2-Hydroxy-1,1-bis(hydroxymethyl)ethyl]-N'-phenylethanediamide including the price, delivery time and more detailed product information at the technical inquiry form on this page

(4,6-Dimethylpyrimidin-2-yl)cyanamide (DMP) is a cyanamide that has been shown to interact with histamine and produce electrophilic products. It is used as an intermediate in the production of methyl anthranilate, which is a precursor to sulfur mustard gas. DMP reacts with alkylating agents such as methyl anthranilate to form compounds that are electrophilic in nature. These compounds can then undergo an electrophilic attack, which results in the formation of new covalent bonds between the reactants.

N-(4-Amino-2-methylphenyl)benzamide (NAPB) is a molecule inhibitor that is designed to inhibit the activity of multiple targets. It inhibits the activity of the enzymes COX and LOX, which are proinflammatory enzymes that are involved in the production of prostaglandins and leukotrienes, respectively. NAPB also has been shown to be an effective antidepressant in animal models. This drug binds to a pharmacophore that exhibits high affinity for both COX and LOX, inhibiting their enzymatic activity by binding at nanomolar concentrations. These properties make NAPB a multitargeted agent with the potential for use against inflammation and depression.

N-Benzyltrifluoroacetamide is an amide that inhibits the activity of the enzyme fatty acid synthase, which catalyzes the synthesis of fatty acids. It has been shown to be effective against a number of cancers and has been used in the treatment of patients infected with HIV. N-Benzyltrifluoroacetamide is active against a range of cancer cell lines, including breast, pancreatic, ovarian, prostate, and colorectal carcinomas. Its mechanism of action is not known but may involve inhibition of protein synthesis or induction of apoptosis.